Investor Presentaiton

CRESCENT POINT | CORPORATE PRESENTATION Transaction Financing & Metrics Purchase Price Equity to HHRS Shareholders ~$2.55B (cash & shares), including ~$455MM in assumed net debt ~$548MM of CPG common shares Transaction Metrics 3.4x net operating income $45,500 per flowing boe Equity Offering -$500MM gross proceeds Debt Funding New three-year term loan totaling $750MM & existing credit facilities $16.93/boe of 2P reserves (including FDC) 2P recycle ratio of 2.2x (including FDC) Transaction metrics reflect: 3.4x - purchase price divided by net operating income reflecting asset level cash flow from the Transaction assuming US$80/bbl WTI, $3.50/mcf AECO and 2024E production of ~56,000 boe/d; $45,500 per flowing boe - purchase price divided by 2024E production of ~56,000 boe/d; $16.93/boe - purchase price plus $2.7B of undiscounted future development capital (FDC) divided by Proved plus Probable (2P) reserves of 308.7 MMBoe as assigned by independent evaluator McDaniel as of November 1, 2023; 2.2x recycle ratio - net operating income, per boe, reflecting asset level cash flow from the acquired assets assuming US$80/bbl WTI, $3.50/mcf AECO and 2024E production of -56,000 boe/d divided by $16.93/boe of 2P reserves 16

View entire presentation